Uncovering the pathogenesis of age-related macular degeneration using induced pluripotent stem cells.

Funding Activity

Website
http://purl.org/au-research/grants/nhmrc/1059369

Funding Status
Closed

Does something not look right? The information on this page has been harvested from data sources that may not be up to date. We continue to work with information providers to improve coverage and quality. To report an issue, use the .

Funded Activity Summary

Age-related macular degeneration (AMD) is a leading cause of blindness in the Western world. There is currently no treatment designed to prevent this loss of vision. We have identified patients with specific genetic risks associated with AMD. We will generate stem cells from these patients, allow the cells to be affected with AMD, then assess the differences and thus establish cellular features associated with each risk. This understanding may lead to uncovering new targets for novel treatments to prevent this common and devastating disease.

Funded Activity Details

Start Date: 01-01-2014

End Date: 01-01-2016

Funding Scheme: Project Grants

Funding Amount: $571,289.00

Funder: National Health and Medical Research Council

Research Topics

ANZSRC Field of Research (FoR)

Optometry and Ophthalmology not elsewhere classified

ANZSRC Socio-Economic Objective (SEO)

There are no SEO codes available for this funding activity

Other Keywords

cell biology | macular degeneration | pathogenesis | retinal disease | stem cells

Related Links